Nanospectra Biosciences snags funding
Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.
8 September 2020•1 min read
Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.